Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM4 | P08173 | 5/20 | 0.74 |
| ▸ | CHRM1 | P11229 | 17/20 | 0.73 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.71 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.71 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL8629348 | 0.93 | CHRM1 (0.71) | CHRM4CHRM1CHRM2CHRM5CHRM3 | |
| SCHEMBL6906570 | 0.89 | CHRM4 (0.81) | CHRM4CHRM1CHRM2CHRM5CHRM3 | |
| SCHEMBL7612265 | 0.88 | CHRM1 (0.80) | CHRM4CHRM1CHRM2CHRM5CHRM3 | |
| SCHEMBL6911734 | 0.87 | CHRM1 (0.82) | CHRM4CHRM1CHRM2CHRM5CHRM3 | |
| SCHEMBL6915589 | 0.85 | CHRM1 (0.73) | CHRM4CHRM1CHRM2CHRM5CHRM3 | |
| SCHEMBL6915593 | 0.85 | CHRM1 (0.73) | CHRM4CHRM1CHRM2CHRM5CHRM3 | |
| SCHEMBL6917329 | 0.85 | CHRM4 (0.71) | CHRM4CHRM1CHRM2CHRM5CHRM3 | |
| SCHEMBL6915584 | 0.85 | CHRM1 (0.73) | CHRM4CHRM1CHRM2CHRM5CHRM3 | |
| SCHEMBL6912678 | 0.84 | CHRM1 (0.72) | CHRM4CHRM1CHRM2CHRM5CHRM3 | |
| SCHEMBL6912682 | 0.84 | CHRM1 (0.72) | CHRM4CHRM1CHRM2CHRM5CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0734259-B1 | Use of piperidine compounds in the treatment of schizophrenia | NOVO NORDISK AS (DK) | 2002-06-12 | — | — | EP | claimed |
| EP-0866702-A1 | METHOD FOR TREATING PAIN | ELI LILLY AND COMPANY (US) | 1998-09-30 | — | — | EP | claimed |
| US-5753683-A | SCHIZOPHRENIA | NOVO NORDISK A/S (DK) | 1998-05-19 | — | — | US | claimed |
| US-5744489-A | ADMINISTERING CERTAIN 1,2,5-THIADIAZOLE AND 1,2,5-OXADIAZOLE COMPOUNDS | GREENWOOD BEVERLEY (US) | 1998-04-28 | — | — | US | claimed |
| US-5712297-A | COGNITION ACTIVATORS; ALZHEIMER*S DISEASE | NOVO NORDISK A/S (DK) | 1998-01-27 | — | — | US | claimed |
| WO-1997020556-A9 | METHOD FOR TREATING PAIN | — | 1997-10-02 | — | — | WO | claimed |
| EP-0788357-A1 | A METHOD OF TREATING URINARY BLADDER DYSFUNCTIONS | NOVO NORDISK A/S (DK) | 1997-08-13 | — | — | EP | claimed |
| WO-1997020556-A1 | METHOD FOR TREATING PAIN | ELI LILLY AND COMPANY (US) | 1997-06-12 | — | — | WO | claimed |
| EP-0734259-A1 | ANTIPSYCHOTIC METHOD | NOVO NORDISK A/S (DK) | 1996-10-02 | — | — | EP | claimed |
| WO-1996014066-A1 | A METHOD OF TREATING URINARY BLADDER DYSFUNCTIONS | NOVO NORDISK A/S (DK) | 1996-05-17 | — | — | WO | claimed |
| WO-1996013168-A1 | METHOD FOR TREATING ANXIETY | ELI LILLY AND COMPANY (US) | 1996-05-09 | — | — | WO | claimed |
| EP-0709095-A2 | Method for treating anxiety using a tetrahydropyridine or azabicyclic oxadiazole or thiadiazole compound | ELI LILLY AND COMPANY (US) | 1996-05-01 | — | — | EP | claimed |
| EP-0384288-B1 | Piperidine compounds and their preparation and use | NOVO NORDISK AS (DK) | 1995-05-24 | — | — | EP | claimed |
| WO-1995005174-A1 | ANTIPSYCHOTIC METHOD | NOVO NORDISK A/S (DK) | 1995-02-23 | — | — | WO | claimed |
| EP-0384288-A2 | Piperidine compounds and their preparation and use | NOVO NORDISK A/S (DK) | 1990-08-29 | — | — | EP | claimed |
| EP-0709094-B1 | Tetrahydropyridine oxadiazole or thiadiazole compound for treating anxiety | LILLY CO ELI (US) | 2000-04-05 | — | — | EP | disclosed |
| EP-0709095-B1 | Method for treating anxiety using a tetrahydropyridine or azabicyclic oxadiazole or thiadiazole compound | LILLY CO ELI (US) | 1999-01-20 | — | — | EP | disclosed |
| EP-0709094-A2 | Method for treating anxiety using a tetrahydropyridine oxadiazole or thiadiazole compound | ELI LILLY AND COMPANY (US) | 1996-05-01 | — | — | EP | disclosed |
| EP-0709095-A2 | Method for treating anxiety using a tetrahydropyridine or azabicyclic oxadiazole or thiadiazole compound | ELI LILLY AND COMPANY (US) | 1996-05-01 | — | — | EP | disclosed |
| US-5488056-A | 1,2,5-THIADIAZOLE COMPOUNDS | ELI LILLY AND COMPANY (US) | 1996-01-30 | — | — | US | disclosed |